Special Issues
August 2018
Volume: 7
Issue: 4
June 2018
April 2018
Contemporary Oncology®: Biomarkers, Pathways, and Targeted Therapies® - March 2018
March 2018
February 2018
Volume: 7
Issue: 1
June 2018
Volume: 7
Issue: 3
April 2018
Volume: 7
Issue: 2
Focus on Pathways: Emerging Mutations in Lung Cancer and Other Solid Tumors
Focus on Pathways: NTRK Gene Fusions
Focus on Pathways: Therapeutic Inhibition of XPO1- Mediated Nucleocytoplasmic Transport With SINE Technology
Focus on Pathways: Next-Generation Sequencing to Support Immuno-Oncology Therapy: The Emerging Role of Tumor Mutational Burden
Focus on Pathways: Novel Targeted Antibody-Drug Conjugates in Non-Hodgkin Lymphoma
December 2017
November 2017
October 2017
Volume: 6
Issue: 5
October 2017
September 2017
August 2017
Volume: 7
Issue: 4
August 2017
July 2017
June 2017
Volume: 6
Issue: 3
June 2017
June 2017
May 2017
Volume: 6
Issue: 2
May 2017
April 2017
March 2017
February 2017
Volume: 6
Issue: 1
February 2017
Advertisement
Advertisement
Trending on OncLive
1
Dr Mesa on the FDA Approval of Ropeginterferon Alfa-2b for Essential Thrombocythemia
2
Zanidatamab Plus Chemotherapy Improves OS at Second Interim Analysis of HERIZON-GEA-01 in First-Line HER2+ GEA
3
Savolitinib Plus Osimertinib Improves First-Line PFS in MET-Overexpressing EGFR-Mutated NSCLC
4
TTFields Add a New Dimension to the Changing Pancreatic Cancer Treatment Paradigm
5